Whitehawk Therapeutics (WHWK) Short-term Investments (2016 - 2026)

Whitehawk Therapeutics (WHWK) has 7 years of Short-term Investments data on file, last reported at $88.3 million in Q1 2026.

• Short-term Investments for Q1 2026 came in at $88.3 million, up 2426.57% year-over-year; the trailing twelve-month figure through Mar 2026 was $88.3 million (up 2426.57% YoY), and the FY2025 annual result was $108.1 million, up 482.37% from the prior year.
• Short-term Investments declined to $88.3 million in Q1 2026 per WHWK's latest filing, from $108.1 million in the prior quarter.
• Over five years, Short-term Investments peaked at $133.5 million in Q4 2022 and troughed at $3.5 million in Q1 2025.
• A 5-year average of $62.8 million and a median of $48.2 million in 2022 frame the typical range for Short-term Investments.
• The sharpest annual moves came in 2025 and 2026: Short-term Investments slumped 89.87% in 2025, then surged 2426.57% in 2026.
• A 5-year view of Short-term Investments shows it stood at $133.5 million in 2022, then slumped by 65.59% to $46.0 million in 2023, then tumbled by 59.6% to $18.6 million in 2024, then soared by 482.37% to $108.1 million in 2025, then declined by 18.38% to $88.3 million in 2026.
• Business Quant data shows WHWK's Short-term Investments at $88.3 million in Q1 2026, $108.1 million in Q4 2025, and $124.7 million in Q3 2025.